Published in

Wiley, British Journal of Haematology, 3(188), p. 404-412, 2019

DOI: 10.1111/bjh.16173

Links

Tools

Export citation

Search in Google Scholar

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Journal article published in 2019 by Fevzi F. Yalniz ORCID, Jesus G. Berdeja, Michael B. Maris, Roger M. Lyons, James A. Reeves, James H. Essell, Prapti Patel, Mikkael Sekeres, Amanda Hughes, Silvia Mappa, Guillermo Garcia‐Manero ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO